MEDILEDGER
DEAD

Serial Number

87446801

Owner

MediLedger LLC

Attorney

Felicia J. Boyd

First Use Date

Mar 27, 2018

Filing Date

May 11, 2017

Add to watchlist:

No watchlists yet
View on USPTO

MEDILEDGER Trademark

Serial Number: 87446801 • Registration: 5891728

MEDILEDGER is a trademark filed by MediLedger LLC on May 11, 2017. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

MediLedger LLC

320 Alabama St., Suite #3
San Francisco, CA 94110

Entity Type: 16

Trademark Details

Filing Date

May 11, 2017

Registration Date

October 22, 2019

First Use Anywhere

March 27, 2018

First Use in Commerce

March 27, 2018

Published for Opposition

December 5, 2017

Cancellation Date

May 8, 2026

Goods & Services

Computer software for the pharmaceutical industry to be used in the control and management of the movement of prescription drugs for counterfeit prevention purposes, namely, software for logging serial numbers and unique identifiers for regulatory compliance purposes and to be used in verification, tracking and tracing pharmaceutical preparations and their ingredients; Computer software for application, data, and database integration and integration of cloud computing environments for the merging, storing, and transmission of data; Computer software for data communications between application programs, networked data sources and cloud computing environments for the transmission of data; Downloadable computer software for the pharmaceutical industry to be used in the control and management of the movement of prescription drugs for counterfeit prevention purposes, namely, software for logging serial numbers and unique identifiers for regulatory compliance purposes and to be used in verification, tracking, and tracing of pharmaceutical preparations and their ingredients

Platform as a service (PAAS) featuring computer software platform for the pharmaceutical industry to be used in the control and management of the movement of prescription drugs for counterfeit prevention purposes, namely, software for logging serial numbers and unique identifiers for regulatory compliance purposes and to be used in to be used in verification, tracking and tracing pharmaceutical preparations and their ingredients; Software as a service (SAAS) services featuring software for the pharmaceutical industry to be used in the control and management of the movement of prescription drugs for counterfeit prevention purposes, namely, software for logging serial numbers and unique identifiers for regulatory compliance purposes and to be used in verification, tracking and tracing pharmaceutical preparations and their ingredients

Filing History

CANCELLED SEC. 8 (6-YR)
May 8, 2026 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Oct 22, 2024 REM1
REGISTERED-PRINCIPAL REGISTER
Oct 22, 2019 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Sep 17, 2019 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Sep 16, 2019 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Aug 24, 2019 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 24, 2019 AITU
USE AMENDMENT FILED
Jul 30, 2019 IUAF
TEAS STATEMENT OF USE RECEIVED
Jul 30, 2019 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 1, 2019 EXRA
SOU EXTENSION 2 GRANTED
Jan 30, 2019 EX2G
SOU EXTENSION 2 FILED
Jan 30, 2019 EXT2
SOU TEAS EXTENSION RECEIVED
Jan 30, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 4, 2018 EXRA
SOU EXTENSION 1 GRANTED
Jul 2, 2018 EX1G
SOU EXTENSION 1 FILED
Jul 2, 2018 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 2, 2018 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 30, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 5, 2017 NPUB
PUBLISHED FOR OPPOSITION
Dec 5, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 15, 2017 NONP
ASSIGNED TO LIE
Oct 27, 2017 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 13, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 23, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 22, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 22, 2017 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Aug 16, 2017 GPRN
PRIORITY ACTION E-MAILED
Aug 16, 2017 GPRA
PRIORITY ACTION WRITTEN
Aug 16, 2017 CPRA
ASSIGNED TO EXAMINER
Aug 9, 2017 DOCK
NOTICE OF PSEUDO MARK E-MAILED
May 17, 2017 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 16, 2017 NWOS
NEW APPLICATION ENTERED
May 15, 2017 NWAP